Frequency Therapeutics Inc (FREQ)
NASDAQ:FREQ
US Market

Frequency Therapeutics (FREQ) Stock Price & Analysis

284 Followers

FREQ Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.33 - $5.59
Previous Close$0.38
Volume48.14K
Average Volume (3M)1.74M
Market Cap
$13.93M
Enterprise ValueN/A
Total Cash (Recent Filing)$46.48M
Total Debt (Recent Filing)$27.81M
Price to Earnings (P/E)-0.2
Beta1.22
Nov 20, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.90
Shares Outstanding36,520,750
10 Day Avg. Volume74,513
30 Day Avg. Volume1,740,875
Standard Deviation0.29
R-Squared0.02
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.31
Price to Sales (P/S)23.48
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

FREQ FAQ

What was Frequency Therapeutics Inc’s price range in the past 12 months?
Frequency Therapeutics Inc lowest stock price was $0.33 and its highest was $5.59 in the past 12 months.
    What is Frequency Therapeutics Inc’s market cap?
    Currently, no data Available
    When is Frequency Therapeutics Inc’s upcoming earnings report date?
    Frequency Therapeutics Inc’s upcoming earnings report date is Nov 20, 2023 which is in 56 days.
      How were Frequency Therapeutics Inc’s earnings last quarter?
      Frequency Therapeutics Inc released its earnings results on Aug 10, 2023. The company reported -$0.3 earnings per share for the quarter, beating the consensus estimate of -$0.356 by $0.056.
        Is Frequency Therapeutics Inc overvalued?
        According to Wall Street analysts Frequency Therapeutics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Frequency Therapeutics Inc pay dividends?
          Frequency Therapeutics Inc does not currently pay dividends.
          What is Frequency Therapeutics Inc’s EPS estimate?
          Frequency Therapeutics Inc’s EPS estimate is -$0.32.
            How many shares outstanding does Frequency Therapeutics Inc have?
            Frequency Therapeutics Inc has 36,520,750 shares outstanding.
              What happened to Frequency Therapeutics Inc’s price movement after its last earnings report?
              Frequency Therapeutics Inc reported an EPS of -$0.3 in its last earnings report, beating expectations of -$0.356. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Frequency Therapeutics Inc?
                Among the largest hedge funds holding Frequency Therapeutics Inc’s share is Perceptive Advisors LLC. It holds Frequency Therapeutics Inc’s shares valued at N/A.

                  ---

                  Frequency Therapeutics Stock Smart Score

                  This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Frequency Therapeutics Inc

                  Frequency Therapeutics, Inc. is a clinical-stage biotechnology company. It engages in the development of small molecule drugs that activate progenitor cells within the body to restore healthy tissue. The company was founded by Robert S. Langer, Jr., David L. Lucchino, Christopher Loose and Will J. McLean in November 13, 2014 and is headquartered in Woburn, MA.

                  ---

                  Top 5 ETFs holding FREQ

                  Name
                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  $598.42K
                  8
                  Up to five ETFs with an Outperform Smart Score that hold FREQ. The ETFs are listed according to market value of FREQ within the ETF

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Apellis Pharmaceuticals
                  Bioxcel Therapeutics
                  Crinetics Pharmaceuticals
                  Denali Therapeutics

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis